10-अगस्त-2024
डाउनलोड पीडीएफ़
Supriya Lifescience
Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please be informed that the Board of Directors of the Company at its Meeting held on Saturday August 10 2024 inter-alia has 1. Considered and approved the Unaudited Financial Results for the Quarter ended June 30 2024 2. Approved the additional Capital Expenditure at Ambernath site for CDMO facility.
वैल्यू रिसर्च से पूछें 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
